INTERPACE BIOSCIENCES, INC. (IDXG)

↓ Download CSV

CIK 0001054102 · OTC · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, INTERPACE BIOSCIENCES, INC. reported revenue of $38.73M, down 17.5% from the prior year. The company was profitable, with a net margin of 63.5% and a gross margin of 62.3%. It held $33.84M in total assets against $11.47M in total liabilities.

Key ratios (FY2025)

62.3%
Gross margin
10.5%
Operating margin
63.5%
Net margin
109.9%
Return on equity
-17.5%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$38.73M$46.93M$40.04M$31.84M$33.12M$32.40M$24.22M$21.90M$15.90M
Cost of Revenue$14.60M$17.00M$14.98M$13.61M$14.31M$21.67M$15.89M$10.20M$7.36M$6.64M
Gross Profit$24.13M$29.93M$25.06M$18.23M$18.80M$10.72M$8.33M$11.70M$8.54M$6.44M
Operating Income$4.08M$8.11M$3.96M-$3.62M-$6.34M-$26.07M-$26.44M-$12.63M-$6.29M-$6.44M
Net Income$24.57M$6.70M$1.95M-$21.96M-$14.94M-$26.45M-$26.74M-$12.70M$12.55M-$22.00M
EPS (Diluted)$5.55$1.42$0.45$-5.18$-3.61
Total Assets$33.84M$14.79M$13.12M$15.98M$38.43M$45.68M$51.54M$31.13M$36.62M$25.14M
Total Liabilities$11.47M$17.01M$22.12M$32.52M$34.31M$28.23M$29.85M$15.68M$13.73M$35.25M
Shareholders' Equity$22.36M-$2.22M-$55.54M-$58.09M-$42.42M-$29.08M-$4.48M$15.45M$22.89M-$10.11M
Cash & Equivalents$2.50M$1.46M$3.50M$4.83M$2.67M$2.77M$2.32M$6.07M$15.20M$602.0K
Operating Cash Flow$5.83M$4.65M$3.79M-$7.69M-$8.72M-$13.98M-$18.96M-$8.67M-$15.26M-$7.61M
Capital Expenditures$356.0K$876.0K$470.0K$322.0K$354.0K$1.57M$131.0K$449.0K$29.0K
Shares Outstanding4.43M4.41M4.35M4.30M4.20M4.06M3.92M2.87M27.84M2.18M